应用LC/TOF-MS分析食管鳞状细胞癌血浆小分子代谢物的实验研究

doi:10.3969/j.issn.1004-616x.2013.06.002

Abstract

Abstract:

OBJECTIVE: The plasma low-molecular weight metabolites of esophageal squamous cell carcinoma were analyzed by liquid chromatography-time of flight- mass spectrography( LC/TOF-MS) to explore potential biomarkers for the early detection of ESCC. METHODS：Plasma samples were obtained from 30 ESCC patients and 30 healthy volunteers，low-molecular weight metabolites were identified by LC/TOF-MS，feature detection was performed by MassHunter software MFE algorithm，statistical analysis was conducted by MPP software，and primary identification was achieved by searching METLIN database. RESULTS：Compared to healthy controls，46 differentially expressed features were detected，13 of which were up-regulated in ESCC group，while the other 33 were down-regulated. After searching with METLIN database，plasma levels of PA，PS，PG were significantly lower in ESCC group. CONCLUSION：ESCC patients are markedly different from healthy people in plasma metabolite composition，and the LC/TOF-MS plasma metabonomics shed light on esophageal cancer early detection and screening.

Key words: metabonomics, liquid chromatography-time of flight-mass spectrography, low-molecular weight metabolites, esophageal squamous cell carcinoma

PENG Yuan，LIU Ran，LI Xiao-bo，YIN Li-hong. A pilot study of plasma metabolic biomarkers for esophageal squamous cell carcinoma by LC/TOF-MS[J]. Carcinogenesis, Teratogenesis & Mutagenesis, doi: 10.3969/j.issn.1004-616x.2013.06.002.

References

[1] Nicholson JK，Lindon JC，Holmes E. “Metabonomics”： understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica，1999， 29 (11)：1181-1189.

[2] Plumb RS，Stumpf CL，Granger JH，et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids[J]. Rapid Commun Mass Spectrom， 2003，17 (23)：2632-2638.

[3] Plumb RS，Stumpf CL，Gorenstein MV，et al. Metabonomics： the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development[J]. Rapid Commun Mass Spectrom， 2002，16 (20)：1991-1996.

[4] Denkert C，Budczies J，Kind T， et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors[J]. Cancer Res，2006，66 (22)：10795-10804.

[5] Ritchie SA，Ahiahonu PWK，Jayasinghe D，et al. Reduced levels of hydroxylated，polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients：implications for early screening and detection[J]. BMC Med，2010，8 (1)：13.

[6] 阿仙姑·哈斯木，巴吐尔·买买提明，伊力亚尔·夏合丁. 不同模式识别方法分析食管癌患者血浆代谢组的磁共振氢谱[J]. 中华肿瘤杂志，2010，32 (9)：681-684.

[7] 杨永霞，梁敏锋，陈阿丽，等. 应用核磁共振代谢组学方法分析食管癌患者血清代谢物[J]. 江苏医药，2010，36 (16)： 1867-1868.

[8] Liscovitch M，Czarny M，Fiucci G，et al. Phospholipase D： molecular and cell biology of a novel gene family[J]. Biochem J，2000，345 (Sup 3)：401-415.

[9] 黄豪博，战榕. 溶血磷脂酸酰基转移酶β与肿瘤关系研究进展[J]. 中国实验血液学杂志，2008，16 (4)：975-978.

[1]	HAINISAYIM·Tursun, ZHANG Zhiqiang, LIU Ling, ZHANG Qiqi, LI Hui. Effects of RNA-binding motif protein X-linked on biological behavior of esophageal carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2025, 37(5): 405-410.
[2]	LU Xiaotong, SHI Jianhong, XIAO Xue, CHEN Siqi, HAO Jiajie, CAI Yan, WANG Mingrong, ZHANG Yu. Involvement of transcriptional enhanced associate domain inhibitor GNE-7883 on malignant phenotypes in esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2025, 37(3): 177-182.
[3]	GUO Jing, XIE Guanchao, WANG Yinong, CAI Yan, ZHANG Yu, WANG Mingrong, HAO Jiajie. High expression of STMN3 and its oncogenic mechanism in esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2025, 37(2): 89-95,104.
[4]	CHEN Jiao, LIU Qing, HUANG Conggai, ZHENG Shutao, LIU Tao, LU Xiaomei. miR-let-7a-5p targeted regulation of SNAP23 and malignant progression of esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2025, 37(1): 63-71.
[5]	HUANG Xiaoyan, WU Fangcai, LIU Cantong, HUANG Jiatao, XU Yiwei. Detection of both serum MMP1 and P53 autoantibody for the diagnosis of esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2024, 36(4): 305-308,324.
[6]	LIU Ruixue, LI Desheng, ZHANG Liwei. Characteristics of serum lipidomics among Kazakhs with esophageal squamous cell carcinomas based on the UPLC-MS/MS method [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2024, 36(1): 21-28,34.
[7]	HUANG Conggai, LIU Qing, ZHENG Shutao, LIU Tao, TAN Yiyi, PENG Tianyuan, CHEN Jiao, LU Xiaomei. Expression of CXCR2 in esophageal cancer tissues and its impact on biological behavior of esophageal cancer cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2024, 36(1): 53-57,65.
[8]	ZHENG Yaqi, ZHAO Ziting, PAN Deyuan, LIU Luxin, XU Xiue, LIAO Liandi, WANG Shaohong, LI Enmin, XU Liyan. The expression of tonsoku-like DNA repair protein in esophageal carcinoma and its effect on the proliferation of esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(6): 412-419.
[9]	WANG Yinong, LIU Guozheng, XIE Guanchao, FENG Dan, LI Sai, CAI Yan, ZHANG Yu, WANG Mingrong, HAO Jiajie. Inhibitory effects of ANXA2 knockdown on malignant phenotype of esophageal squamous carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(6): 445-451.
[10]	LIU Ruixue, ZHANG Liwei. Expression and significance of AMPK esophageal squamous cell carcinoma among Kazakhs [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(4): 285-291.
[11]	SHI Jianhong, CHEN Dingxiong, LU Xiaotong, HAO Jiajie, CAI Yan, WANG Mingrong, ZHANG Yu. Inhibitory effect of ICG-001 on proliferation of esophageal squamous carcinoma cells and its molecular mechanisms [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(3): 187-191,196.
[12]	FENG Dan, FAN Zhilu, WANG Yinong, LI Sai, GUO Jing, CAI Yan, ZHANG Yu, WEI Wenqiang, WANG Mingrong, HAO Jiajie. P4HA2 promotes proliferation of esophageal squamous carcinoma cells via activating the EGFR/AKT/S6 signaling pathway [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2023, 35(2): 87-94,101.
[13]	LI Ziyao, ZHANG Haiping, MADINIYET·Niyaz, JULATI·Ainiwaer, ZHANG Liwei, EDRIS·Awut. Clinicopathological significance of cystatin 6 protein expression in Kazakh esophageal squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(6): 429-433,438.
[14]	CUI Wenxuan, JIAO Wenjing, ZHAO Wei, DU Yanyan, TIAN Guo, ZHANG Jinyan, MA Ming. Clinical values of combined FIB, FAR and serum tumor markers in diagnosis and progression of ESCC patients [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(4): 289-294,326.
[15]	YANG Xingxiao, ZHANG Xueyuan, ZOU Naiyi, SHAN Bao'en, MA Ming, ZHU Shuchai. Effects of HMGB1 silencing on migration, invasion and radiosensitivity of esophageal squamous cell carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 327-333.

A pilot study of plasma metabolic biomarkers for esophageal squamous cell carcinoma by LC/TOF-MS

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments